The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Buflomedil for intermittent claudication
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2013
|
| DOI | 10.1002/14651858.cd000988.pub4 |
| Pubmed ID | |
| Authors |
Tine LM de Backer, Robert Vander Stichele |
| Abstract |
Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease. However, its clinical efficacy for IC has not yet been critically examined. This is an update of a Cochrane review first published in 2000, and previously updated in 2007 and 2008. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Egypt | 1 | 33% |
| United Kingdom | 1 | 33% |
| Venezuela, Bolivarian Republic of | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 124 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 16 | 13% |
| Researcher | 15 | 12% |
| Student > Master | 15 | 12% |
| Student > Ph. D. Student | 13 | 10% |
| Other | 9 | 7% |
| Other | 13 | 10% |
| Unknown | 43 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 29% |
| Nursing and Health Professions | 20 | 16% |
| Psychology | 6 | 5% |
| Social Sciences | 4 | 3% |
| Computer Science | 2 | 2% |
| Other | 13 | 10% |
| Unknown | 43 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2020.
All research outputs
#15,666,386
of 26,128,906 outputs
Outputs from Cochrane database of systematic reviews
#10,963
of 13,194 outputs
Outputs of similar age
#119,519
of 212,250 outputs
Outputs of similar age from Cochrane database of systematic reviews
#171
of 210 outputs
Altmetric has tracked 26,128,906 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,194 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,250 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 210 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.